Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNHS weight loss injections are available to adults in England, but the criteria are strict and phased in gradually. Whether you qualify depends on your BMI, how many weight-related health conditions you have, and where you live — and right now, only a small portion of eligible adults can actually access treatment through their GP or a specialist service. This page sets out the current NHS thresholds honestly, so you know exactly where you stand. These medicines are prescription-only, assessed by a clinician before any prescription is issued.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
In England, two medicines are recommended by NICE for weight management: tirzepatide (Mounjaro) and semaglutide (Wegovy). Each has its own set of thresholds, and both are being made available through the NHS in stages rather than all at once.
For tirzepatide, NICE's appraisal (TA1026) sets the baseline at a BMI of 35 or above, alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease. As of June 2025, NHS England began prescribing to people with a BMI of 40 or above who have four or more of those five qualifying conditions. From June 2026, that opened up to people with a BMI between 35 and 39.9 who also have four or more qualifying conditions. A further expansion to those with a BMI of 40-plus and three qualifying conditions is expected around March 2027.
For semaglutide (Wegovy), NICE's recommendation (TA875) requires a specialist weight management service referral and is currently limited to a two-year maximum course. BMI thresholds are similar, though access depends heavily on local specialist service availability and waiting lists, which in many areas are long.
Across both medicines, BMI thresholds are 2.5 kg/m² lower for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds under UK clinical guidance.
From 1 April 2026, GP practices in England may prescribe tirzepatide under the new GP contract. This is optional for practices, not mandatory, so availability differs considerably depending on your surgery and local integrated care board. Some GPs are prescribing now; others are waiting for additional funding or guidance. It is worth asking your practice directly rather than assuming the door is open or closed.
For Wegovy, access in England has historically required a referral to a specialist weight management service, which adds time. NHS England's guidance on weight management injections explains the wraparound care requirements that come with NHS prescribing, including dietary support and activity guidance that patients must engage with alongside the medicine.
Meeting the clinical criteria on paper does not guarantee an NHS prescription. Capacity, your practice's participation, and local waiting times all play a role. Many people find the timing works against them, a referral that arrives after a job change, a house move, or simply months of waiting. That gap is where a private route becomes relevant.
Private treatment is a completely separate, legal pathway. A GPhC-registered online pharmacy can prescribe tirzepatide or semaglutide to adults who meet the licensed eligibility criteria for private prescriptions: broadly, a BMI of 30 or above, or 27 or above with at least one weight-related condition. These thresholds come from the medicines' licensed indications rather than NHS commissioning rules, so they are wider than the current NHS criteria.
The process still involves a real clinical assessment. At nume, a GPhC-registered Independent Prescriber reviews every consultation personally, you can read more about our clinical team and how we work on our about us page. Identity is verified, weight is confirmed on a live video call, and GP notification follows in line with GPhC guidance. If approved, treatment is dispatched the same day for orders placed before 12pm on a weekday, with free next-working-day DPD delivery.
For a fuller picture of how private and NHS routes compare, our page on weight loss injections on the NHS sets out both options side by side. And if you want to understand more about the full range of options available privately, our weight loss injections overview covers what is currently licensed and dispensed.
Yes, meaningfully. NHS England's phased rollout described above applies in England only. Scotland operates its own access pathway through NHS Scotland, with different BMI thresholds and clinical criteria; NHS Inform Scotland is the most accurate source for current Scottish eligibility. Wales and Northern Ireland each commission weight management medicines separately, and availability varies by health board. If you live outside England, checking with your GP or the relevant national health service is the most reliable first step rather than applying England's rules to your situation.
Private eligibility through a regulated pharmacy is the same across the UK, the licensed indications do not vary by nation, and nume does not apply different criteria depending on your postcode. A private prescription is assessed on clinical grounds alone. If you are unsure whether you might qualify privately, our guide to eligibility for a weight loss injection on the NHS goes into further detail on the criteria involved, and you can ask any questions through our contact page before starting a consultation. When you are ready, learning about how the weight loss injection works on the NHS and checking your eligibility with our prescribers is free and carries no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.